ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2025 Earnings Call Transcript November 7, 2025
ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $2.04, expectations were $1.74.
Operator: Good morning, everyone, and welcome to today’s ANI Pharmaceuticals Third Quarter 2025 Earnings Results Call. Please note, this call is being recorded. [Operator Instructions] It is now my pleasure to turn the conference over to Ms. Courtney Mogerley, Investor Relations. Please go ahead,...
